|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/30 | (2006.01) |
| C07K 16/28 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| C07K 16/40 | (2006.01) | ||
| G01N 33/574 | (2006.01) |
| (11) | Number of the document | 3088421 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16152641.3 |
| Date of filing the European patent application | 2013-07-03 | |
| (97) | Date of publication of the European application | 2016-11-02 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-27 |
| (46) | Date of publication of the claims translation | 2019-04-10 |
| (30) | Number | Date | Country code |
| 201261669967 P | 2012-07-10 | US | |
| 201261702916 P | 2012-09-19 | US |
| (72) |
Molldrem, Jeffrey, US
Sergeeva, Anna, US
|
| (73) |
Board of Regents, The University of Texas System,
210 West 7th Street, Austin, TX 78701,
US
|
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
| (54) | Monokloniniai antikūnai, skirti panaudoti vėžio ir autoimuninių ligų diagnozei ir gydymui |
| MONOCLONAL ANTIBODIES FOR USE IN DIAGNOSIS AND THERAPY OF CANCERS AND AUTOIMMUNE DISEASE |
| Payment date | Validity (years) | Amount | |
| 2022-07-01 | 10 | 231.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-07-03 |